Most Popular Stories
- Debt payments still mire HCA
- Cleveland Clinic lists potential conflicts of interest online
- A new strategy for harried physicians: See patients in groups
- Forum: IT won't help much until practices shift operations
- Fitch changes not-for-profit hospital outlook to negative
- HFMA ANI 2008: Advice on preparing for a Medicare audit
- Disruptive doctor behavior causes mistakes, intimidates workers
- AHA survey: Negative profit margins for hospitals
- DOD, VA move to SOA architecture to build interoperable systems
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- Cleveland Clinic lists potential conflicts of interest online
- A new strategy for harried physicians: See patients in groups
Poll
Featured Jobs
-
Colorado NP or PA
StaffPointe, LLC - southeast , CO -
Texas Hospitalist
StaffPointe, LLC - south , TX -
Florida Med Peds
StaffPointe, LLC - Panhandle , FL -
CA Operations Coord/Manager/Cardio
StaffPointe, LLC - Modesto , CA -
California Radialogy Tech Cath Lab
StaffPointe, LLC - Modesto , CA
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Popular Topics
Vioxx lawsuits continue to multiply
Following the $253 million jury award in Ernst v. Merck, thousands of people have filed new lawsuits against the drug maker over its painkiller Vioxx. Court documents show that 1,500 new suits have been filed against the company in the eight weeks since the case ended. That brings the total number of suits filed against the company over its maligned Cox-2 inhibitor to 6,500. The award in the Texas case was capped under state laws limiting punitive damages, reducing it dramatically, but that hasn't stopped the verdict from inspiring the follow-on suits. The attorney representing the plaintiff in the Atlantic City Vioxx trial said he expects as many as 10,000 to 15,000 additional suits to be filed in New Jersey by the end of the year.
- see this article from the Boston Globe
Related Stories
- Merck's position seen as tenuous
- FL, IA legislatures pass CON reforms
- GAO report details problems at FDA
- SPOTLIGHT: Scientists stand by Vioxx research
- Merck scores victory in second Vioxx trial
- Lanier 'Dream Team' to file thousands of new Vioxx claims
- SPOTLIGHT: A little pain relief for Merck
- Jury awards Ernst $253.5M in Vioxx suit
- Second Vioxx trial opens in NJ
- Judge rebukes Merck attorney in Vioxx case
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





